Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filedlitigationCriticalhttps://patents.darts-ip.com/?family=38734884&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UY29877(A1)"Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US11/262,113external-prioritypatent/US20060189635A1/en
Application filed by Alza CorpfiledCriticalAlza Corp
Publication of UY29877A1publicationCriticalpatent/UY29877A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Medicinal Preparation
(AREA)
Abstract
Se revelan métodos y formas de dosificación que comprenden derivados de benzisoxazol. Más particularmente, se revelan métodos, formas de dosificación, y nuevos usos de derivados de benzisoxazol que proveen eficacia mejorada cuando se utilizan en el tratamiento de la esquizofrenia y/o de la manía bipolar.Methods and dosage forms comprising benzisoxazole derivatives are disclosed. More particularly, methods, dosage forms, and new uses of benzisoxazole derivatives are disclosed which provide improved efficacy when used in the treatment of schizophrenia and / or bipolar mania.
UY29877A2005-10-192006-10-19
METHODS AND DOSAGE FORMS OF BENZISOXAZOL DERIVATIVES WITH BETTER EFFECTIVENESS.
UY29877A1
(en)
Use of compound genz-112638 (eliglustat), glucosylceramide synthase inhibitor, in the treatment of gaucher disease and fabry disease (divisional application 201201348).
MACROCICLOS COMPOUNDS, SELECTIVE INHIBITORS OF SERIOAPROTEASA VIEW COAGULATION FACTOR; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE IN THE TREATMENT OF A THROMBOEMBOLIC DISORDER.
COMPOUNDS DERIVED FROM HETEROCICLES REPLACED WITH MORFOLINA, INHIBITORS OF THE ACTIVITY OF PI3 QUINASA; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; PHARMACEUTICAL KIT; AND ITS USE IN THE CANCER PROFILACTIC OR THERAPEUTIC TREATMENT
Compounds derived from 17-beta-cyano-18 alpha-homo-19-nor-androst-4-eno; presenting gestagenic and antimineralcorticoid activity; pharmaceutical composition; and use in the treatment of pre-peri-and postmenopausal disorders and premenstrual disorders.
COMPOUNDS DERIVED FROM [4,5 '] - BIPIRIMIDINIL-6,4'-DIAMINE; PHARMACEUTICAL COMPOSITION; AND USE AS AN INHIBITOR OF THE ACTIVITY OF CINASA IN CANCER DE VEJIGA, CANCER CERVICAL AND MIELOMA MULTIPLE.
Compounds derived from 2,7-naphthyridines-1-one, mediators of syk; pharmaceutical composition; and use in the treatment of inflammatory, respiratory, cellular proliferative or autoimmune disease.
COMPOUNDS DERIVED FROM INDOL WITH UNITED RING IN POSITIONS 4,5; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND TO TREAT A VIRAL INFECTION.
Heterocycle substituted phenylpiperidine derivative compounds; preparation procedure; pharmaceutical composition comprising it; and use in the treatment of cardiovascular, thromboembolic and tumor disorders; in vitro uses.
COMPOUNDS DERIVED FROM OCTAHIDRO-PIRROLO [3,4-C] PIRROL; PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS IT; AND USE OF THE COMPOUND IN THE TREATMENT OF HIV, AIDS OR ARC.
Compounds derived from substituted phenylamino-benzene; Preparation method; pharmaceutical composition; farm kit; and use of said compounds in the treatment of cancer.